Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com

Share Article

RnRMarketResearch.com adds “Muscle Spasm – Pipeline Review, H1 2015” to its store. The report provides an overview of the Muscle Spasm’s therapeutic pipeline.

The report “Muscle Spasm – Pipeline Review, H1 2015” provides comprehensive information on the therapeutic development for Muscle Spasm. Spasms may affect many different types of muscles in the body, leading to many different symptoms and presentations. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report on H1 2015 pipeline review of Axillary Hyperhidrosis with 19 market data tables and 15 figures, spread across 42 pages is available at http://www.rnrmarketresearch.com/muscle-spasm-pipeline-review-h1-2015-market-report.html .

Companies discussed in this Axillary Hyperhidrosis – Pipeline Review, H1 2015 report include Actavis plc, Brickell Biotech, Inc., Dermira Inc., GlaxoSmithKline plc, Revance Therapeutics, Inc., TheraVida, Inc.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are (diclofenac sodium + eperisone), (ketoprofen + nifedipine), Drug to Agonize TRPA1 and TRPV1 for Neuromuscular Disorders, NVP-1102, RT-002, tolperisone.

Scope of this report includes: The report provides a snapshot of the global therapeutic landscape of Muscle Spasm; The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities; The report reviews key players involved in the therapeutics development for Muscle Spasm and enlists all their major and minor projects; The report summarizes all the dormant and discontinued pipeline projects; A review of the Muscle Spasm products under development by companies and universities/research institutes based on information derived from company and industry-specific sources; Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages; A detailed assessment of monotherapy and combination therapy pipeline projects; Coverage of the Muscle Spasm pipeline on the basis of target, MoA, route of administration and molecule type as well as Latest news and deals relating related to pipeline products.

Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=382515 . (This is a premium report priced at US$2000 for a single user License.)

List of Tables
Number of Products under Development for Muscle Spasm, H1 2015 7
Number of Products under Development for Muscle Spasm - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Late Stage Development, H1 2015 10
Comparative Analysis by Clinical Stage Development, H1 2015 11
Comparative Analysis by Early Stage Development, H1 2015 12
Products under Development by Companies, H1 2015 13
Muscle Spasm - Pipeline by Eisai Co., Ltd., H1 2015 14
Muscle Spasm - Pipeline by Omeros Corporation, H1 2015 15
Muscle Spasm - Pipeline by Revance Therapeutics, Inc., H1 2015 16
Muscle Spasm - Pipeline by Sanochemia Pharmazeutika AG, H1 2015 17
Assessment by Monotherapy Products, H1 2015 18
Assessment by Combination Products, H1 2015 19
Number of Products by Stage and Target, H1 2015 21
Number of Products by Stage and Mechanism of Action, H1 2015 23
Number of Products by Stage and Route of Administration, H1 2015 25
Number of Products by Stage and Molecule Type, H1 2015 27
Muscle Spasm Therapeutics - Recent Pipeline Updates, H1 2015 36
Muscle Spasm - Dormant Projects, H1 2015 38

List of Figures
Number of Products under Development for Muscle Spasm, H1 2015 7
Number of Products under Development for Muscle Spasm - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Late Stage Development, H1 2015 10
Comparative Analysis by Clinical Stage Development, H1 2015 11
Assessment by Monotherapy Products, H1 2015 18
Assessment by Combination Products, H1 2015 19
Number of Products by Top 10 Targets, H1 2015 20
Number of Products by Stage and Top 10 Targets, H1 2015 20
Number of Products by Top 10 Mechanism of Actions, H1 2015 22
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 22
Number of Products by Top 10 Routes of Administration, H1 2015 24
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 25
Number of Products by Top 10 Molecule Types, H1 2015 26
Number of Products by Stage and Top 10 Molecule Types, H1 2015 27

Explore more reports on Therapeutics at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics .

About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
@RnRMR
since: 06/2012
Follow >
RnR Market Research
Like >
Follow us on
Visit website